1. [Sparse evidence of antipsychotic drugs for the treatment of delirium].
- Author
-
Andersen CU, Høimark L, Dabrowski K, Hansen KB, and Sædder E
- Subjects
- Amisulpride, Benzodiazepines therapeutic use, Evidence-Based Medicine, Humans, Olanzapine, Piperazines therapeutic use, Quetiapine Fumarate therapeutic use, Risperidone therapeutic use, Sulpiride analogs & derivatives, Sulpiride therapeutic use, Thiazoles therapeutic use, Antipsychotic Agents therapeutic use, Delirium drug therapy
- Abstract
Traditionally, haloperidol has been the recommended antipsychotic drug for pharmacological treatment of delirium, which is a frequent complication in the critical care setting. Due to a less frequent occurrence of extrapyramidal adverse effects, second-generation antipsychotic drugs have been evaluated. In the present paper we review the current randomized prospective studies of second-generation antipsychotics as treatment for delirium in hospitalized patients and conclude that so far the evidence in favour of these drugs compared with haloperidol is still sparse.
- Published
- 2014